AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Cohen & Steers Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Joseph M. Harvey, Chief Executive Officer and director of Cohen & Steers, Inc. (CNS), reported a Form 4 filing documenting an internal accrual of dividend-equivalent restricted stock units. The filing shows 1,170 shares were acquired on 08/21/2025 as dividend-equivalent restricted stock units that vested (or were credited) at a price of $0. The report also discloses beneficial holdings including 1,287,031 shares reported following the transaction and 305,000 shares held indirectly through an LLC owned by a family trust, of which Mr. Harvey disclaims beneficial ownership except to the extent of his pecuniary interest. The form was signed by an attorney-in-fact on 08/22/2025.

Joseph M. Harvey, Chief Executive Officer e membro del consiglio di Cohen & Steers, Inc. (CNS), ha presentato un Modulo 4 che documenta l'accredito interno di unità azionarie vincolate equivalenti ai dividendi. Il documento indica che 1.170 azioni sono state acquisite il 21/08/2025 come unità azionarie vincolate equivalenti ai dividendi, vestite (o accreditate) a un prezzo di $0. La segnalazione riporta inoltre le partecipazioni di beneficio, incluse 1.287.031 azioni risultanti dopo la transazione e 305.000 azioni detenute indirettamente tramite una LLC controllata da un trust familiare, di cui il signor Harvey rinnega la titolarità beneficiaria salvo per la quota del suo interesse pecuniario. Il modulo è stato firmato da un procuratore il 22/08/2025.

Joseph M. Harvey, Director Ejecutivo y miembro del consejo de Cohen & Steers, Inc. (CNS), presentó un Formulario 4 que documenta la contabilización interna de unidades restringidas equivalentes a dividendos. El informe indica que 1.170 acciones se adquirieron el 21/08/2025 como unidades restringidas equivalentes a dividendos que se consolidaron (o acreditaron) a un precio de $0. El reporte también revela participaciones beneficiarias, incluidas 1.287.031 acciones reportadas tras la transacción y 305.000 acciones mantenidas indirectamente a través de una LLC propiedad de un fideicomiso familiar, de las cuales el Sr. Harvey renuncia a la titularidad beneficiaria salvo por su interés pecuniario. El formulario fue firmado por un apoderado el 22/08/2025.

Cohen & Steers, Inc. (CNS)ì� 최고경ì˜ìž� ê²� ì´ì‚¬ì� Joseph M. Harveyê°€ 배당 등가 제한주ì‹ìˆ˜ìµê¶Œì˜ ë‚´ë¶€ ì ë¦½ì� 문서화한 Form 4ë¥� 제출했습니다. 제출서류ì—� 따르ë©� 1,170주가 2025-08-21ì—� 배당 등가 제한주ì‹ìˆ˜ìµê¶Œìœ¼ë¡� ì·¨ë“ë˜ì—ˆìœ¼ë©°, 해당 수ìµê¶Œì€ ê°€ê²� $0ë¡� 베스íŒ�(ë˜ëŠ” ì ë¦½)ë˜ì—ˆìŠµë‹ˆë‹�. 신고서ì—ëŠ� 거래 í›� ë³´ê³ ë� 1,287,031ì£�ì� 실소ìœ� 지분과, ê°€ì¡� ì‹ íƒì� 소유í•� LLCë¥� 통해 ê°„ì ‘ 보유í•� 305,000ì£�ê°€ í¬í•¨ë˜ì–´ 있으ë©�, Harvey 씨는 ìžì‹ ì� 금전ì � ì´ìµ 범위ë¥� 제외í•� 유ìµì†Œìœ ê¶Œì„ ë¶€ì¸í•˜ê³� 있습니다. 해당 ì–‘ì‹ì€ 2025-08-22ì—� 대리ì¸ì—� ì˜í•´ 서명ë˜ì—ˆìŠµë‹ˆë‹�.

Joseph M. Harvey, Président-directeur général et administrateur de Cohen & Steers, Inc. (CNS), a déclaré dans un Formulaire 4 l'inscription interne d'unités d'actions restreintes équivalentes au dividende. Le dépôt indique que 1 170 actions ont été acquises le 21/08/2025 sous forme d'unités d'actions restreintes équivalentes au dividende, vestées (ou créditées) à un prix de 0 $. Le rapport divulgue également les participations bénéficiaires, incluant 1 287 031 actions déclarées après la transaction et 305 000 actions détenues indirectement via une LLC détenue par un trust familial, dont M. Harvey décline la propriété bénéficiaire sauf dans la mesure de son intérêt pécuniaire. Le formulaire a été signé par un mandataire le 22/08/2025.

Joseph M. Harvey, Chief Executive Officer und Direktor von Cohen & Steers, Inc. (CNS), meldete in einer Form 4 die interne Gutschrift von dividendenäquivalenten Restricted Stock Units. Die Meldung zeigt, dass am 21.08.2025 insgesamt 1.170 Aktien als dividendenäquivalente Restricted Stock Units erworben wurden, die zu einem Preis von $0 vested (oder gutgeschrieben) wurden. Der Bericht legt ferner vorteilhafte Bestände offen, darunter 1.287.031 Aktien, die nach der Transaktion gemeldet wurden, sowie 305.000 Aktien, die indirekt über eine von einem Familientrust gehaltene LLC gehalten werden; Herr Harvey bestreitet die vorteilhafte Inhaberschaft außer in dem Umfang seines pecuniären Interesses. Das Formular wurde am 22.08.2025 von einem Bevollmächtigten unterschrieben.

Positive
  • Acquisition of 1,170 dividend-equivalent RSUs credited to existing unvested restricted stock units, reflecting continued compensation alignment with shareholders
  • Substantial reported beneficial ownership following the transaction (1,287,031 shares) indicating significant insider stake
  • 305,000 shares held indirectly via an LLC associated with a family trust, showing additional retained economic interest
Negative
  • None.

Insights

TL;DR: Routine insider crediting of dividend-equivalent RSUs; significant aggregate holdings remain largely unchanged.

The Form 4 documents a non-cash accrual of 1,170 dividend-equivalent restricted stock units to the CEO, consistent with compensation practices tied to outstanding restricted stock grants from 2022-2025. The filing also clarifies an indirect block of 305,000 shares held through an LLC associated with a family trust, with a disclaimer of beneficial ownership except for pecuniary interest. This is a standard disclosure reflecting compensation mechanics and retained insider stake; it does not indicate a deliberate buy or sell decision by the reporting person.

TL;DR: Small non-cash issuance, large insider stake persists; minimal immediate market impact.

The reported acquisition of 1,170 shares at $0 are dividend-equivalent RSUs credited to unvested grants and therefore represent compensation accounting rather than market purchases. The aggregate post-transaction beneficial ownership of 1,287,031 shares (plus 305,000 indirectly held via an LLC) indicates substantial insider alignment with shareholders. Because the transaction is non-cash and modest in size relative to total holdings, it is unlikely to affect trading volumes or valuation in the near term.

Joseph M. Harvey, Chief Executive Officer e membro del consiglio di Cohen & Steers, Inc. (CNS), ha presentato un Modulo 4 che documenta l'accredito interno di unità azionarie vincolate equivalenti ai dividendi. Il documento indica che 1.170 azioni sono state acquisite il 21/08/2025 come unità azionarie vincolate equivalenti ai dividendi, vestite (o accreditate) a un prezzo di $0. La segnalazione riporta inoltre le partecipazioni di beneficio, incluse 1.287.031 azioni risultanti dopo la transazione e 305.000 azioni detenute indirettamente tramite una LLC controllata da un trust familiare, di cui il signor Harvey rinnega la titolarità beneficiaria salvo per la quota del suo interesse pecuniario. Il modulo è stato firmato da un procuratore il 22/08/2025.

Joseph M. Harvey, Director Ejecutivo y miembro del consejo de Cohen & Steers, Inc. (CNS), presentó un Formulario 4 que documenta la contabilización interna de unidades restringidas equivalentes a dividendos. El informe indica que 1.170 acciones se adquirieron el 21/08/2025 como unidades restringidas equivalentes a dividendos que se consolidaron (o acreditaron) a un precio de $0. El reporte también revela participaciones beneficiarias, incluidas 1.287.031 acciones reportadas tras la transacción y 305.000 acciones mantenidas indirectamente a través de una LLC propiedad de un fideicomiso familiar, de las cuales el Sr. Harvey renuncia a la titularidad beneficiaria salvo por su interés pecuniario. El formulario fue firmado por un apoderado el 22/08/2025.

Cohen & Steers, Inc. (CNS)ì� 최고경ì˜ìž� ê²� ì´ì‚¬ì� Joseph M. Harveyê°€ 배당 등가 제한주ì‹ìˆ˜ìµê¶Œì˜ ë‚´ë¶€ ì ë¦½ì� 문서화한 Form 4ë¥� 제출했습니다. 제출서류ì—� 따르ë©� 1,170주가 2025-08-21ì—� 배당 등가 제한주ì‹ìˆ˜ìµê¶Œìœ¼ë¡� ì·¨ë“ë˜ì—ˆìœ¼ë©°, 해당 수ìµê¶Œì€ ê°€ê²� $0ë¡� 베스íŒ�(ë˜ëŠ” ì ë¦½)ë˜ì—ˆìŠµë‹ˆë‹�. 신고서ì—ëŠ� 거래 í›� ë³´ê³ ë� 1,287,031ì£�ì� 실소ìœ� 지분과, ê°€ì¡� ì‹ íƒì� 소유í•� LLCë¥� 통해 ê°„ì ‘ 보유í•� 305,000ì£�ê°€ í¬í•¨ë˜ì–´ 있으ë©�, Harvey 씨는 ìžì‹ ì� 금전ì � ì´ìµ 범위ë¥� 제외í•� 유ìµì†Œìœ ê¶Œì„ ë¶€ì¸í•˜ê³� 있습니다. 해당 ì–‘ì‹ì€ 2025-08-22ì—� 대리ì¸ì—� ì˜í•´ 서명ë˜ì—ˆìŠµë‹ˆë‹�.

Joseph M. Harvey, Président-directeur général et administrateur de Cohen & Steers, Inc. (CNS), a déclaré dans un Formulaire 4 l'inscription interne d'unités d'actions restreintes équivalentes au dividende. Le dépôt indique que 1 170 actions ont été acquises le 21/08/2025 sous forme d'unités d'actions restreintes équivalentes au dividende, vestées (ou créditées) à un prix de 0 $. Le rapport divulgue également les participations bénéficiaires, incluant 1 287 031 actions déclarées après la transaction et 305 000 actions détenues indirectement via une LLC détenue par un trust familial, dont M. Harvey décline la propriété bénéficiaire sauf dans la mesure de son intérêt pécuniaire. Le formulaire a été signé par un mandataire le 22/08/2025.

Joseph M. Harvey, Chief Executive Officer und Direktor von Cohen & Steers, Inc. (CNS), meldete in einer Form 4 die interne Gutschrift von dividendenäquivalenten Restricted Stock Units. Die Meldung zeigt, dass am 21.08.2025 insgesamt 1.170 Aktien als dividendenäquivalente Restricted Stock Units erworben wurden, die zu einem Preis von $0 vested (oder gutgeschrieben) wurden. Der Bericht legt ferner vorteilhafte Bestände offen, darunter 1.287.031 Aktien, die nach der Transaktion gemeldet wurden, sowie 305.000 Aktien, die indirekt über eine von einem Familientrust gehaltene LLC gehalten werden; Herr Harvey bestreitet die vorteilhafte Inhaberschaft außer in dem Umfang seines pecuniären Interesses. Das Formular wurde am 22.08.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harvey Joseph M

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 305,000 I By LLC(1)
Common Stock 08/21/2025 A 1,170(2) A $0 1,287,031 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares held in a limited liability company owned by a family trust. Mr. Harvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
2. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joseph M. Harvey report on Form 4 for CNS?

He reported the acquisition of 1,170 dividend-equivalent restricted stock units credited on 08/21/2025 and disclosed existing beneficial holdings.

How many shares does the filing show after the transaction?

The filing shows 1,287,031 shares beneficially owned following the reported transaction.

What is the nature of the 305,000 shares listed in the Form 4?

The 305,000 shares are held indirectly by an LLC owned by a family trust; Mr. Harvey disclaims beneficial ownership except to the extent of his pecuniary interest.

Was cash paid for the 1,170 shares reported?

No; the transaction price is listed as $0, reflecting dividend-equivalent restricted stock units credited to unvested RSUs.

When was the Form 4 signed and filed?

The signature by attorney-in-fact is dated 08/22/2025 and the transaction date is 08/21/2025.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.89B
27.43M
46.04%
60.35%
3.77%
Asset Management
Investment Advice
United States
NEW YORK